Eli Lilly Italia Competitors and Similar CompaniesClear all

Eli Lilly Italia's competitors and similar companies include Colinz Laboratories, Lilly, Astellas Pharma and Esteve Quimica.

	Eli Lilly Italia Eli Lilly Italia is a company that develops, discovers, produces, and distributes pharmaceutical products.	Colinz Laboratories Colinz Laboratories is a manufacturer of allopathic and Ayurvedic pharmaceutical products.	Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.	Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.	Esteve Quimica Esteve Quimica is a company developing, manufacturing, and marketing oral and injectable-non-sterile APIs (active pharmaceutical ingredient).
Founding Date	Founding Date 1959	Founding Date 1986	Founding Date 1876	Founding Date 1923	Founding Date 1966
Type	Type Subsidiary	Type Public	Type Public	Type Public	Type Private
Tags	Tags Manufacturing & Industrial diabetes drug development oncology pharma	Tags Manufacturing & Industrial diabetes drug development pharma	Tags Manufacturing & Industrial diabetes drug development oncology pharma	Tags Healthcare diabetes drug development oncology pharma	Tags Healthcare diabetes drug development oncology pharma
Locations	Locations Sesto Fiorentino, IT HQ	Locations HQ	Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more	Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more	Locations Barcelona, ES HQ Shaoxing Shi, CN Barcelona, ES Celrà, ES
Employees	Employees 1,300	Employees N/A	Employees 47,0009% increase	Employees 14,754	Employees 934
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 903.4 b	Valuation ($) 20.8 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₹61.4m (FY, 2026)	Revenue (est.) $65.2b (FY, 2025)	Revenue (est.) ¥2.1t (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ₹17.1m (FY, 2026)	Cost of goods $11.1b (FY, 2025)	Cost of goods ¥213.8b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ₹49.1m (FY, 2026)	Gross profit $54.1b (FY, 2025)	Gross profit ¥2t (FY, 2026)	Gross profit N/A
Net income	Net income N/A	Net income ₹5.1m (FY, 2026)	Net income $20.6b (FY, 2025)	Net income ¥291.6b (FY, 2026)	Net income N/A